Clinical Trial Update: Corneal Cross Linking and Topography Guided Excimer Laser Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial investigating corneal cross-linking with topography-guided excimer laser treatment for keratoconus and Pellucid Marginal Degeneration was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus
• Pellucid Marginal Degeneration

Snippet

Sponsor: Medical University of Vienna | Conditions: Keratoconus, Pellucid Marginal Degeneration | Phase 3 | Status: TERMINATED